BDSX
Biodesix Inc
NASDAQ: BDSX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$23.50
+6.33% today
Updated 2026-08-07
Market cap
$221.51M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-3.98
Dividend yield
—
52W range
$5 – $25
Volume
0.1M
Biodesix Inc (BDSX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$23.50
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$8.93
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -33.30%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.